Dihydrothiophene derivatives as insecticidal compounds

US10517294B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10517294-B2
Application numberUS-201314441304-A
CountryUS
Kind codeB2
Filing dateNov 8, 2013
Priority dateNov 9, 2012
Publication dateDec 31, 2019
Grant dateDec 31, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides compounds of formula (I) wherein Q is Q1 or Q2 P is P0, heterocyclyl or heterocyclyl substituted by one to five Z; Y 1 , Y 2 , Y 3 and Y 4 are independently of each other C—H, C—R 5 , or nitrogen; G 1 is oxygen or sulfur; R 1 is hydrogen, C 1 -C 8 alkyl, C 1 -C 8 alkoxy-, C 1 -C 8 alkylcarbonyl-, or C 1 -C 8 alkoxycarbonyl-; X 4 is C 1 -C 8 haloalkyl; R 4 is aryl or aryl substituted by one to five R 9 , or heteroaryl or heteroaryl substituted by one to five R 9 ; n is 0, 1 or 2; and Z, R 2 , R 5 and R 9 are as defined in the claims. The invention also provides methods of controlling insects, acarines, nematodes or molluscs comprising applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I).

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) wherein Q is Q1 or Q2 wherein P is P0, heterocyclyl or heterocyclyl substituted by one to five Z; Y 2 , Y 3 and Y are independently of each other C—H, C—R 5 , or nitrogen; G 1 is oxygen or sulfur; R 1 is hydrogen, C 1 -C 8 alkyl, C 1 -C 8 alkoxy-, C 1 -C 8 alkylcarbonyl-, or C 1 -C 8 alkoxycarbonyl-; R 2 is C 1 -C 8 alkyl or C 1 -C 8 alkyl substituted by one to five R 6 , C 2 -C 8 alkenyl or C 2 -C 8 alkenyl substituted by one to five R 6 , C 2 -C 8 alkynyl or C 2 -C 8 alkynyl substituted by one to five R 6 , C 3 -C 10 cycloalkyl or C 3 -C 10 cycloalkyl substituted by one to five R 7 , C 3 -C 10 cycloalkyl-C 1 -C 4 alkanediyl or C 3 -C 10 cycloalkyl-C 1 -C 4 alkanediyl substituted by one to five R 7 , C 3 -C 10 cycloalkenyl or C 3 -C 10 cycloalkenyl substituted by one to five R 7 , C 3 -C 10 cycloalkenyl-C 1 -C 4 alkanediyl or C 3 -C 3 -C 10 cycloalkenyl-C 1 -C 4 alkanediyl substituted by one to five R 7 , aryl-C 1 -C 4 alkanediyl or aryl-C 1 -C 4 alkanediyl in which the aryl moiety is substituted by one to five R 8 , heterocyclyl-C 1 -C 4 alkanediyl or heterocyclyl-C 1 -C 4 alkanediyl in which the heterocyclyl moiety is substituted by one to five R 8 , aryl-N(R 20 )— or aryl-N(R 20 )— in which the aryl moiety is substituted by one to five R 8 , heterocyclyl-N(R 20 )— or heterocyclyl-N(R 20 )— in which the heterocyclyl moiety is substituted by one to five R 8 , aryl or aryl substituted by one to five R 8 , heterocyclyl or heterocyclyl substituted by one to five R 8 , C 1 -C 8 alkylaminocarbonyl-C 1 -C 4 alkanediyl, C 1 -C 8 haloalkylaminocarbonyl-C 1 -C 4 alkanediyl, C 3 -C 8 cycloalkyl-aminocarbonyl-C 1 -C 4 alkanediyl, C 1 -C 8 alkylaminocarbonyl-, C 1 -C 8 haloalkylaminocarbonyl, C 3 -C 8 cycloalkyl-aminocarbonyl, C 1 -C 8 alkyl-O—N═CH—, or C 1 -C 6 haloalkyl-O—N═CH—, and in which a bridging alkanediyl moiety optionally includes a —C(R 21 )(R 22 )— unit as bridge member; or R 1 and R 2 together represent group A G 2 is O(R 13 ), N(R 14 )(R 15 ) or S(R 16 ); G 3 is N(R 17 )(R 18 ) or S(R 19 )); X 4 is C 1 -C 8 haloalkyl; R 4 is aryl or aryl substituted by one to five R 9 , or heteroaryl or heteroaryl substituted by one to five R 9 ; each R 5 is independently hydrogen, halogen, cyano, nitro, NH 2 , C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -C 8 haloalkynyl, C 3 -C 10 cycloalkyl, C 1 -C 8 alkoxy-, C 1 -C 8 haloalkoxy-, C 1 -C 8 alkylthio-, C 1 -C 8 haloalkylthio-, C 1 -C 8 alkylsulfinyl-, C 1 -C 8 haloalkylsulfinyl-, C 1 -C 8 alkylsulfonyl-, or C 1 -C 8 haloalkylsulfonyl-; or two R 5 on adjacent carbon atoms together form a —CH═CH—CH═CH— bridge; each R 6 is independently halogen, cyano, nitro, hydroxy, amino, C 1 -C 8 alkylamino, (C 1 -C 8 alkyl) 2 amino, C 1 -C 8 alkylcarbonylamino, C 1 -C 8 haloalkylcarbonylamino, C 1 -C 8 alkoxy-, C 1 -C 8 haloalkoxy-, aryloxy or aryloxy substituted by one to five R 10 , aryloxy-C1-C 4 alkanediyl or aryloxy-C1-C 4 alkanediyl in which the aryl moiety is substituted by one to five R 10 , C 1 -C 8 alkylcarbonyl-, C 1 -C 8 alkoxycarbonyl-, mercapto, C 1 -C 8 haloalkylthio-, C 1 -C 8 alkylsulfinyl-, C 1 -C 8 haloalkylsulfinyl-, C 1 -C 8 alkylsulfonyl-, C 1 -C 8 haloalkylsulfonyl-, aryl-C 1 -C 4 alkanediylthio or aryl-C 1 -C 4 alkanediylthio in which the aryl moiety is substituted by one to five R 10 ; each R 7 is independently halogen, cyano, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 1 -C 8 alkyl-O—N═, C 1 -C 8 haloalkyl-O—N═, C 1 -C 8 alkoxy, C 1 -C 4 alkoxy-C 1 -C 4 alkyl, or C 1 -C 8 alkoxycarbonyl; each R 8 is independently halogen, cyano, nitro, oxo, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 1 -C 8 cyanoalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -C 8 haloalkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkyl-C 1 -C 4 alkanediyl, hydroxy, C 1 -C 8 alkoxy-, C 1 -C 8 haloalkoxy-, mercapto, C 1 -C 8 alkylthio-, C 1 -C 8 haloalkylthio-, C 1 -C 8 haloalkylsulfinyl-, C 1 -C 8 alkylsulfonyl-, C 1 -C 8 haloalkylsulfonyl-, C 1 -C 8 alkylaminosulfonyl, (C 1 -C 8 alkyl) 2 aminosulfonyl-, C 1 -C 8 alkylcarbonyl-, C 1 -C 8 alkoxycarbonyl-, aryl or aryl substituted by one to five R 10 , heterocyclyl or heterocyclyl substituted by one to five R 10 , aryl-C 1 -C 4 alkanediyl- or aryl-C 1 -C 4 alkanediyl- in which the aryl moiety is substituted by one to five R 10 , heterocyclyl-C 1 -C 4 alkanediyl or heterocyclyl-C 1 -C 4 alkanediyl in which the heterocyclyl moiety is substituted by one to five R 10 , aryloxy or aryloxy substituted by one to five R 10 , aryloxy-C 1 -C 4 alkanediyl or aryloxy-C 1 -C 4 alkanediyl in which the aryl moiety is substituted by one to five R 10 ; each R 9 is independently halogen, cyano, nitro, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -C 8 haloalkynyl, hydroxy, C 1 -C 8 alkoxy-, C 1 -C 8 haloalkoxy-, mercapto, C 1 -C 8 haloalkylthio-, C 1 -C 8 alkylsulfinyl-, C 1 -C 8 haloalkylsulfinyl-, C 1 -C 8 alkylsufonyl-, C 1 -C 8 haloalkylsulfonyl-, C 1 -C 8 alkylcarbonyl-, C 1 -C 8 alkoxycarbonyl-, aryl or aryl substituted by one to five R 10 , or heterocyclyl or heterocyclyl substituted by one to five R 10 ; each R 10 is independently halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy-, or C 1 -C 4 haloalkoxy-; each Z is independently halogen, C 1 -C 12 alkyl or C 1 -C 12 alkyl substituted by one to five R 6 , nitro, C 1 -C 12 alkoxy or C 1 -C 12 alkoxy substituted by one to five R 6 , cyano, C 1 -C 12 alkylsulfinyl, C 1 -C 12 alkylsulfonyl, C 1 -C 12 haloalkylsulfinyl, C 1 -C 12 haloalkylsulfonyl, hydroxyl or thiol; R 13 , R 16 and R 19 are independently C 1 -C 4 alkyl; R 14 , R 15 , R 17 , and R 18 are independently hydrogen or C 1 -C 4 alkyl; R 20 is hydrogen or C 1 -C 4 alkyl; each R 21 and R 22 is independently halogen or C 1 -C 4 alkyl, or optionally together form a C 3 -C 4 alkanediyl bridge; n is 0, 1 or 2; or a salt or N-oxide thereof. 2. The compound according to claim 1 , wherein Q is Q1. 3. The compound according to claim 1 , wherein Y 1 is C—R 5 , C—H or nitrogen, Y 2 and Y 3 are independently C—H or nitrogen and Y 4 is C—R 5 ; in which no more than two of Y 1 , Y 2 and Y 3 are nitrogen and in which Y 2 and Y 3 are not both nitrogen, and wherein two R 5 when present on adjacent carbon atoms together form a —CH═CH—CH═CH— bridge. 4. The compound according to claim 1 , wherein G 1 is oxygen. 5. The compound according to claim 1 , wherein P is P0 or a heterocycle selected from H1 to H9 k is 0, 1 or 2. 6. The compound according to claim 1 , wherein R 1 is hydrogen, methyl, ethyl, methylcarbonyl-, or methoxycarbonyl-. 7. The compound according to claim 1 , wherein R 2 is C 1 -C 8 alkyl or C 1 -C 8 alkyl substituted by one to five R 6 , C 3 -C 10 cycloalkyl or C 3 -C 10 cycloalkyl substituted by one to five R 7 , aryl-C 1 -C 4 alkanediyl or aryl-C 1 -C 4 alkanediyl in which the aryl moiety is substituted by one to five R 8 , heterocyclyl-C 1 -C 4 alkanediyl or hete

Assignees

Inventors

Classifications

  • Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • Thiophene-2-carboxylic acid · CPC title

  • Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • Oxygen atoms · CPC title

  • Aromatic or araliphatic carboxylic acids, or thio analogues thereof; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10517294B2 cover?
The present invention provides compounds of formula (I) wherein Q is Q1 or Q2 P is P0, heterocyclyl or heterocyclyl substituted by one to five Z; Y 1 , Y 2 , Y 3 and Y 4 are independently of each other C—H, C—R 5 , or nitrogen; G 1 is oxygen or sulfur; R 1 is hydrogen, C 1 -C 8 alkyl, C 1 -C 8 alkoxy-, C 1 -C 8 alkylcarbonyl-, or C 1 -C 8 alkoxycarbonyl-; X 4 is C 1 -C 8 haloalkyl; R 4 is…
Who is the assignee on this patent?
Syngenta Participations Ag
What technology area does this patent fall under?
Primary CPC classification A01N43/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).